Harmony Biosciences Hldgs Affirms Prelim FY2026 Sales Guidance of $1.000B-$1.040B vs $1.014B Est

Harmony Biosciences Hldgs (NASDAQ: HRMY ) affirms prelim FY2026 sales outlook from $1.000 billion-$1.040 billion to $1.000 billion-$1.040 billion vs $1.014 billion estimate.